CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 157 filers reported holding CONMED CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $27,000 | -99.2% | 343 | -99.3% | 0.00% | -100.0% |
| Q2 2020 | $3,534,000 | +21.1% | 49,094 | -3.7% | 0.02% | -11.8% |
| Q1 2020 | $2,919,000 | +68.5% | 50,980 | +229.3% | 0.02% | +112.5% |
| Q4 2019 | $1,732,000 | +2410.1% | 15,480 | +1827.8% | 0.01% | – |
| Q2 2019 | $69,000 | -95.5% | 803 | -95.7% | 0.00% | -100.0% |
| Q1 2019 | $1,544,000 | +217.7% | 18,562 | +145.1% | 0.01% | +250.0% |
| Q4 2018 | $486,000 | -21.4% | 7,572 | -3.0% | 0.00% | -33.3% |
| Q3 2018 | $618,000 | +158.6% | 7,804 | +139.3% | 0.00% | +200.0% |
| Q2 2018 | $239,000 | -32.1% | 3,261 | -59.1% | 0.00% | -50.0% |
| Q2 2014 | $352,000 | -76.9% | 7,977 | -77.2% | 0.00% | -75.0% |
| Q1 2014 | $1,523,000 | +1011.7% | 35,049 | +984.4% | 0.01% | +700.0% |
| Q4 2013 | $137,000 | +63.1% | 3,232 | +30.1% | 0.00% | 0.0% |
| Q3 2013 | $84,000 | – | 2,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |